PharmaCyte Biotech PMCB Q1 2026 Earnings Narrowing Loss Amid Strategic Pipeline Progress Ovintiv OVV Q1 2026 Earnings EPS Beats Estimates by 669 Amid Operational Efficiency DSGR Q1 2026 Earnings EPS Exceeds Estimates Despite Stock Decline ClearOne CLRO Q2 2018 Earnings Narrowing Losses Exceeds Analyst Expectations SUPV Q1 2026 Earnings Massive EPS Beat Surprises Market Stock Declines Despite Strong Performance Chord Energy CHRD Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Efficiency Gains